145 related articles for article (PubMed ID: 21862569)
1. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today?
Altmäe S; Hovatta O; Stavreus-Evers A; Salumets A
Hum Reprod Update; 2011; 17(6):813-28. PubMed ID: 21862569
[TBL] [Abstract][Full Text] [Related]
2. Allelic estrogen receptor 1 (ESR1) gene variants predict the outcome of ovarian stimulation in in vitro fertilization.
Altmäe S; Haller K; Peters M; Hovatta O; Stavreus-Evers A; Karro H; Metspalu A; Salumets A
Mol Hum Reprod; 2007 Aug; 13(8):521-6. PubMed ID: 17540666
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics in ovarian stimulation--current concepts.
Loutradis D; Vlismas A; Drakakis P; Antsaklis A
Ann N Y Acad Sci; 2008 Apr; 1127():10-9. PubMed ID: 18443324
[TBL] [Abstract][Full Text] [Related]
4. Association of allelic combinations of FSHR gene polymorphisms with ovarian response.
Desai SS; Achrekar SK; Paranjape SR; Desai SK; Mangoli VS; Mahale SD
Reprod Biomed Online; 2013 Oct; 27(4):400-6. PubMed ID: 23953588
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization.
La Marca A; Sighinolfi G; Argento C; Grisendi V; Casarini L; Volpe A; Simoni M
Fertil Steril; 2013 Mar; 99(4):970-8.e1. PubMed ID: 23380184
[TBL] [Abstract][Full Text] [Related]
6. Genetic profile of SNP(s) and ovulation induction.
Loutradis D; Theofanakis C; Anagnostou E; Mavrogianni D; Partsinevelos GA
Curr Pharm Biotechnol; 2012 Mar; 13(3):417-25. PubMed ID: 21657995
[TBL] [Abstract][Full Text] [Related]
7. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
8. Ovarian response to standard gonadotrophin stimulation for IVF is decreased not only in older but also in younger women in couples with idiopathic and male subfertility.
Goverde AJ; McDonnell J; Schats R; Vermeiden JP; Homburg R; Lambalk CB
Hum Reprod; 2005 Jun; 20(6):1573-7. PubMed ID: 15746195
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers.
Morón FJ; Ruiz A
Pharmacogenomics; 2010 Nov; 11(11):1613-8. PubMed ID: 21121812
[TBL] [Abstract][Full Text] [Related]
10. Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?
Orvieto R; Meltzer S; Rabinson J; Gemer O; Anteby EY; Nahum R
Fertil Steril; 2008 Oct; 90(4):1297-300. PubMed ID: 18249369
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology of the FSH receptor: new insights into FSH physiology.
Meduri G; Bachelot A; Cocca MP; Vasseur C; Rodien P; Kuttenn F; Touraine P; Misrahi M
Mol Cell Endocrinol; 2008 Jan; 282(1-2):130-42. PubMed ID: 18248882
[TBL] [Abstract][Full Text] [Related]
12. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.
Fauser BC; Diedrich K; Devroey P;
Hum Reprod Update; 2008; 14(1):1-14. PubMed ID: 18006561
[TBL] [Abstract][Full Text] [Related]
13. Effect of follicle-stimulating hormone receptor Asn680Ser polymorphism on the outcomes of controlled ovarian hyperstimulation: an updated meta-analysis of 16 cohort studies.
Tang H; Yan Y; Wang T; Zhang T; Shi W; Fan R; Yao Y; Zhai S
J Assist Reprod Genet; 2015 Dec; 32(12):1801-10. PubMed ID: 26481502
[TBL] [Abstract][Full Text] [Related]
14. Association of estrogen, progesterone and follicle stimulating hormone receptor polymorphisms with in vitro fertilization outcomes.
Ganesh V; Venkatesan V; Koshy T; Reddy SN; Muthumuthiah S; Paul SFD
Syst Biol Reprod Med; 2018 Aug; 64(4):260-265. PubMed ID: 29916276
[TBL] [Abstract][Full Text] [Related]
15. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
[TBL] [Abstract][Full Text] [Related]
16. Role of treatment with ovarian stimulation and intrauterine insemination in women with unilateral tubal occlusion diagnosed by hysterosalpingography.
Farhi J; Ben-Haroush A; Lande Y; Fisch B
Fertil Steril; 2007 Aug; 88(2):396-400. PubMed ID: 17445812
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism FSHR (-29G/A) as a genetic agent together with ESRI (XbaIG/A) in women with poor response to controlled ovarian hyperstimulation.
Zamaniara T; Taheripanah R; Ghaderian SMH; Zamaniara E; Aghabozorgi SSA
Hum Antibodies; 2017; 26(3):143-147. PubMed ID: 29526845
[TBL] [Abstract][Full Text] [Related]
18. Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin.
Grøndahl ML; Borup R; Lee YB; Myrhøj V; Meinertz H; Sørensen S
Fertil Steril; 2009 May; 91(5):1820-30. PubMed ID: 18439596
[TBL] [Abstract][Full Text] [Related]
19. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of controlled ovarian hyperstimulation.
de Castro F; Morón FJ; Montoro L; Real LM; Ruiz A
Pharmacogenomics; 2005 Sep; 6(6):629-37. PubMed ID: 16143002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
